Latest Conference Articles

Adding Avastin to Lonsurf Improved Outcomes in Pretreated Colorectal Cancer

Adding Avastin to Lonsurf Improved Outcomes in Pretreated Colorectal Cancer

January 25th 2023, 2:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with pretreated metastatic colorectal cancer had better outcomes when Avastin was added to their Lonsurf treatment in the third line setting.

SBRT Reduces Side Effects, Treatment Visits in Pancreatic Cancer

SBRT Reduces Side Effects, Treatment Visits in Pancreatic Cancer

January 24th 2023, 10:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

Better Quality of Life Reported with Minimally Invasive Esophageal Cancer Treatment

Better Quality of Life Reported with Minimally Invasive Esophageal Cancer Treatment

January 23rd 2023, 10:00pm

ASCO Gastrointestinal Cancers Symposium

Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.

Lenvima May Prolong Survival in Advanced Liver Cancer That Progressed on Immunotherapy

Lenvima May Prolong Survival in Advanced Liver Cancer That Progressed on Immunotherapy

January 23rd 2023, 2:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with advanced HCC who progressed after treatment with immunotherapy may have a survival benefit when treated with second-line Lenvima.

Quitting Smoking and Drinking May Decrease Depression Risk After Gastric Cancer Surgery

Quitting Smoking and Drinking May Decrease Depression Risk After Gastric Cancer Surgery

January 22nd 2023, 6:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with gastric cancer who quit smoking and/or drinking after undergoing a gastrectomy tended to have a decreased risk of depression, research showed.

Novel Drug-Chemo Combo May Offer ‘New Standard of Care’ for Certain GI Cancers

Novel Drug-Chemo Combo May Offer ‘New Standard of Care’ for Certain GI Cancers

January 21st 2023, 7:00pm

ASCO Gastrointestinal Cancers Symposium

Zolbetuximab plus mFOLFOX6 lengthened the time to progression for patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction (GEJ) adenocarcinoma.

HER2-Low Gastric Cancer May Be a Distinct Disease Subtype

HER2-Low Gastric Cancer May Be a Distinct Disease Subtype

January 20th 2023, 10:00pm

ASCO Gastrointestinal Cancers Symposium

Patients with HER2-low gastric cancer tended to have distinct characteristics compared to those with HER2-negative or -positive disease, warranting more research into this group, research found.

Educated Patient® MPN Summit Myelofibrosis Panel: November 19, 2022

Educated Patient® MPN Summit Myelofibrosis Panel: November 19, 2022

December 18th 2022, 3:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Aaron Gerds and Dr. Andrew Kuykendall answer questions about myelofibrosis during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Myelofibrosis Second-Line Treatment and Beyond Presentation: November 19, 2022

Educated Patient® MPN Summit Myelofibrosis Second-Line Treatment and Beyond Presentation: November 19, 2022

December 17th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Andrew Kuykendall, from the Mofitt Cancer Center, discuss second-line treatments and beyond for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

Educated Patient® MPN Summit First-line Treatment in Myelofibrosis Presentation: November 19, 2022

Educated Patient® MPN Summit First-line Treatment in Myelofibrosis Presentation: November 19, 2022

December 16th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch to Dr. Naveen Pemmaraju, from The University of Texas MD Anderson Cancer Center, discuss frontline treatment options for patients with myelofibrosis during the CURE® Educated Patient® MPN Summit.

Educated Patient® MPN Summit Polycythemia Vera Panel: November 19, 2022

Educated Patient® MPN Summit Polycythemia Vera Panel: November 19, 2022

December 15th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Jamile Shammo and Dr. John Mascarenhas answer questions about polycythemia vera during the CURE Educated Patient MPN Summit.

Survival and Treatment Response May Be Further Improved With Brukinsa Versus Imbruvica for CLL/SLL

Survival and Treatment Response May Be Further Improved With Brukinsa Versus Imbruvica for CLL/SLL

December 14th 2022, 8:00pm

American Society of Hematology Annual Meeting

Progression-free survival and overall response rates greatly improved in patients with CLL/SLL treated with Brukinsa compared with Imbruvica.

Educated Patient® MPN Summit Future Treatment of Polycythemia Vera Presentation: November 19, 2022

Educated Patient® MPN Summit Future Treatment of Polycythemia Vera Presentation: November 19, 2022

December 14th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. John Mascarenhas, from the Icahn School of Medicine at Mount Sinai, discuss future treatments for polycythemia vera, during the CURE Educated Patient MPN Summit.

Calquence Tends to Be a Shorter-Lived Frontline Regimen Than Imbruvica for Leukemia Subtype

Calquence Tends to Be a Shorter-Lived Frontline Regimen Than Imbruvica for Leukemia Subtype

December 13th 2022, 10:00pm

American Society of Hematology Annual Meeting

Patients with chronic lymphocytic leukemia tended to switch to another regimen or intensify their Calquence treatment quicker than those given Imbruvica, study results showed.

Educated Patient® MPN Summit Current Treatment Options in Polycythemia Vera Presentation: November 19, 2022

Educated Patient® MPN Summit Current Treatment Options in Polycythemia Vera Presentation: November 19, 2022

December 13th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Jamile M. Shammo, from Northwestern University Feinberg School of Medicine, discuss current treatment options in polycythemia vera during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Essential Thrombocythemia Panel: November 19, 2022

Educated Patient® MPN Summit Essential Thrombocythemia Panel: November 19, 2022

December 12th 2022, 1:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Aaron Gerds and Dr. Douglas Tremblay answer questions about essential thrombocythemia during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Current and Future Treatments of Essential Thrombocythemia Presentation: November 19, 2022

Educated Patient® MPN Summit Current and Future Treatments of Essential Thrombocythemia Presentation: November 19, 2022

December 11th 2022, 4:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Douglas A. Tremblay, from Mount Sinai, discuss treatment for essential thrombocythemia during the CURE Educated Patient MPN Summit.

Educated Patient® MPN Summit Defining Essential Thrombocythemia Risk Presentation: November 19, 2022

Educated Patient® MPN Summit Defining Essential Thrombocythemia Risk Presentation: November 19, 2022

December 10th 2022, 8:00pm

Educated Patient® MPN Summit: November 19, 2022

Watch Dr. Aaron T. Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss essential thrombocythemia risk during the CURE Educated Patient MPN Summit.

Educated Patient® Multiple Myeloma Summit Looking Ahead Panel: November 13, 2022

Educated Patient® Multiple Myeloma Summit Looking Ahead Panel: November 13, 2022

December 9th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Francesco Maura, Dr. Marcella Kaddoura and Mary DeRome answer questions about the future of myeloma during the CURE® Educated Patient® Multiple Myeloma Summit.

Cognitive Ability May Worsen More With Chemotherapy Plus Endocrine Therapy Versus Endocrine Therapy Alone for Breast Cancer

Cognitive Ability May Worsen More With Chemotherapy Plus Endocrine Therapy Versus Endocrine Therapy Alone for Breast Cancer

December 8th 2022, 10:00pm

SABCS

Patients with breast cancer, regardless of their menopausal status, may face worse cognitive ability with chemotherapy and endocrine therapy, although this may return to its pretreatment level after 36 months.

Educated Patient® Multiple Myeloma Summit Precision Medicine Presentation: November 13, 2022

Educated Patient® Multiple Myeloma Summit Precision Medicine Presentation: November 13, 2022

December 8th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Marcella Kaddoura, from Miami Sylvester Comprehensive Cancer Center, discuss targeting myeloma with small molecules with precision medicine during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Predicting Clinical Outcomes Presentation: November 13, 2022

Educated Patient® Multiple Myeloma Summit Predicting Clinical Outcomes Presentation: November 13, 2022

December 7th 2022, 2:19pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Francesco Maura, from Miami Sylvester Comprehensive Cancer Center, discuss how personalized prediction models can be used to identify the best treatments during the CURE® Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Treating Myeloma Long-Term Panel: November 13, 2022

Educated Patient® Multiple Myeloma Summit Treating Myeloma Long-Term Panel: November 13, 2022

December 6th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Valarie Traynham, of the HealthTree Foundation, discuss the long-term journey of the disease and disparities still seen during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Therapy and Beyond Panel: November 13, 2022

Educated Patient® Multiple Myeloma Summit Therapy and Beyond Panel: November 13, 2022

December 5th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Dickran Kazandjian and Dr. Benjamin Diamond answer questions about therapeutic options during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Role of Sustained MRD Negativity Presentation: November 13, 2022

Educated Patient® Multiple Myeloma Summit Role of Sustained MRD Negativity Presentation: November 13, 2022

December 4th 2022, 3:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Benjamin T. Diamond, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of sustained MRD negativity during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Immunotherapy Presentation: November 13, 2022

Educated Patient® Multiple Myeloma Summit Immunotherapy Presentation: November 13, 2022

December 3rd 2022, 3:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. Dickran Kazandjian, from the Sylvester Comprehensive Cancer Center at the University of Miami, discuss available immunotherapy options during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Disease Overview Panel: November 13, 2022

Educated Patient® Multiple Myeloma Summit Disease Overview Panel: November 13, 2022

December 2nd 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. C. Ola Landgren and Dr. David Coffey answer questions about novel treatments and the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Role of the Healthy Immune System Presentation: November 13, 2022

Educated Patient® Multiple Myeloma Summit Role of the Healthy Immune System Presentation: November 13, 2022

December 1st 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. David Coffey, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss the role of a healthy immune system during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Novel Treatments for the Newly Diagnosed Presentation: November 13, 2022

Educated Patient® Multiple Myeloma Summit Novel Treatments for the Newly Diagnosed Presentation: November 13, 2022

November 30th 2022, 2:00pm

Educated Patient® Multiple Myeloma Summit: November 13, 2022

Watch Dr. C. Ola Landgren, from Sylvester Comprehensive Cancer Center at the University of Miami, discuss novel treatments for newly diagnosed patients during the CURE® Educated Patient® Multiple Myeloma Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Unmet Needs Panel: November 12, 2022

Educated Patient® Metastatic Breast Cancer Summit Addressing Unmet Needs Panel: November 12, 2022

November 29th 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.